Skip to main content
رجوع
Watch Compare

CITIUS ONCOLOGY, INC.

جودة البيانات: 83%
CTOR
Nasdaq Manufacturing Chemicals
KWD 0.66
▲ KWD 0.02 (2.79%)
القيمة السوقية: 58.27 M
السعر
KWD 0.66
القيمة السوقية
58.27 M
نطاق اليوم
KWD 0.62 — KWD 0.67
نطاق 52 أسبوعًا
KWD 0.49 — KWD 6.19
حجم التداول
80,221
فتح KWD 0.63
متوسط 50 يوم / 200 يوم
KWD 0.96
30.94% below
متوسط 50 يوم / 200 يوم
KWD 1.59
58.51% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -12.85 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-52.06%
أقل من متوسط القطاع (-51.02%)
ROIC-43.72%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio0.83
Interest Coverage-109.05

التقييم

PE (TTM)
-2.47
أقل من متوسط القطاع (-1.98)
P/B Ratio1.00
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -2.5 -2.0
P/B 1.0 5.1
ROE % -52.1 -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -23.64 M
ROE -52.06% ROA -23.44%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -12.85 M
ROIC -43.72% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.83
Interest Coverage -109.05 Asset Turnover N/A
Working Capital -7.56 M Tangible Book Value 58.41 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2.47 Forward P/E N/A
P/B Ratio 1.00 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -22.05%
Market Cap 58.27 M Enterprise Value 50.98 M
Per Share
EPS (Diluted TTM) -0.31 Revenue / Share N/A
FCF / Share -0.15 OCF / Share -0.15
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 54.35%
SBC-Adj. FCF -22.83 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Revenue — — — —
Net Income -24.76 M -21.15 M 2.42 M 380,811.0
EPS (Diluted) -0.34 -0.31 0.27 0.12
Gross Profit — — — —
Operating Income -23.52 M — -1.01 M -138,115.0
EBITDA — — — —
R&D Expenses 6.42 M 4.93 M — —
SG&A Expenses — — — —
D&A — — — —
Interest Expense 218,032.0 — — —
Income Tax 1.06 M 576,000.0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022
Total Assets 100.94 M 84.37 M 72.62 M 68.19 M
Total Liabilities 56.08 M 38.23 M — —
Shareholders' Equity 44.87 M 46.14 M -1.99 M 345,508.0
Total Debt — — — —
Cash & Equivalents — — — —
Current Assets 27.54 M 10.97 M 58,200.0 377,344.0
Current Liabilities 49.49 M 32.70 M 2.05 M 31,836.0